|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer: Apr 5, 2021 (Epub ahead of
print).
|
|
3
|
Soomro Z, Youssef M, Yust-Katz S, Jalali
A, Patel AJ and Mandel J: Paraneoplastic syndromes in small cell
lung cancer. J Thorac Dis. 12:6253–6263. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Henry K: Paraneoplastic syndromes:
Definitions, classification, pathophysiology and principles of
treatment. Semin Diagn Pathol. 36:204–210. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Thapa B, Mahendraker N and Ramphul K:
Paraneoplastic syndromes. [Updated 2023 Mar 31]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing, 2025.
|
|
6
|
Anwar A, Jafri F, Ashraf S, Jafri MAS and
Fanucchi M: Paraneoplastic syndromes in lung cancer and their
management. Ann Transl Med. 7(359)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dimitriadis GK, Angelousi A, Weickert MO,
Randeva HS, Kaltsas G and Grossman A: Paraneoplastic endocrine
syndromes. Endocr Relat Cancer. 24:R173–R190. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Onyema MC, Drakou EE and Dimitriadis GK:
Endocrine abnormality in paraneoplastic syndrome. Best Pract Res
Clin Endocrinol Metab. 36(101621)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schwartz WB, Bennett W, Curelop S and
Bartter FC: A syndrome of renal sodium loss and hyponatremia
probably resulting from inappropriate secretion of antidiuretic
hormone. Am J Med. 23:529–542. 1975.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Amatruda TT Jr, Mulrow PJ, Gallagher JC
and Sawyer WH: Carcinoma of the lung with inappropriate
antidiuresis. Demonstration of antidiuretic-hormone-like activity
in tumor extract. N Engl J Med. 269:544–549. 1963.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Adrogué HJ, Tucker BM and Madias NE:
Diagnosis and management of hyponatremia: A review. JAMA.
328:280–291. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sun NH, Wang SH, Liu JN, Liu A, Gong WJ,
Liu Y, Sun P and Li H: The productions of atrial natriuretic
peptide and arginine vasopressin in small cell lung cancer with
brain metastases and their associations with hyponatremia. Eur Rev
Med Pharmacol Sci. 21:4104–4112. 2017.PubMed/NCBI
|
|
13
|
Ghosal A, Qadeer HA, Nekkanti SK, Pradhan
P, Okoye C and Waqar D: A conspectus of euvolemic hyponatremia, its
various etiologies, and treatment modalities: A comprehensive
review of the literature. Cureus. 15(e43390)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sørensen JB, Andersen MK and Hansen HH:
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
in malignant disease. J Intern Med. 238:97–110. 1995.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Warren AM, Grossmann M, Christ-Crain M and
Russell N: Syndrome of inappropriate antidiuresis: From
pathophysiology to management. Endocr Rev. 44:819–861.
2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mc Donald D, Drake MT and Crowley RK:
Treatment of hypercalcaemia of malignancy in adults. Clin Med
(Lond). 23:503–507. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Feldenzer KL and Sarno J: Hypercalcemia of
malignancy. J Adv Pract Oncol. 9:496–504. 2018.PubMed/NCBI
|
|
18
|
Giannetta E, Sesti F, Modica R,
Grossrubatscher EM, Ragni A, Zanata I, Colao A and Faggiano A: What
lies behind paraneoplastic hypercalcemia secondary to
well-differentiated neuroendocrine neoplasms? A systematic review
of the literature. J Pers Med. 12(1553)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Goltzman D: Approach to hypercalcemia.
[Updated 2023 Apr 17]. In: Feingold KR, Anawalt B, Blackman MR,
Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K,
Hofland L et al (eds). In: Endotext [Internet]. South
Dartmouth (MA): MDText.com, Inc., 2000.
|
|
20
|
Almuradova E and Cicin I: Cancer-related
hypercalcemia and potential treatments. Front Endocrinol
(Lausanne). 14(1039490)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
O'Callaghan S and Yau H: Treatment of
malignancy-associated hypercalcemia with cinacalcet: A paradigm
shift. Endocr Connect. 10:R13–R24. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li WY, Liu XD, Li WN, Dong SY, Qu XH, Gong
SL, Shao MR and Zhang L: Paraneoplastic Cushing's syndrome
associated with bronchopulmonary carcinoid tumor in youth: A case
report and review of the literature. Oncol Lett. 12:69–72.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Galli J and Greenlee J: Paraneoplastic
diseases of the central nervous system. F1000Res: F1000 Faculty
Rev-167, 2020.
|
|
24
|
Castinetti F: Medical management of
Cushing's disease: When and how? J Neuroendocrinol.
34(e13120)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Granberg D, Juhlin CC, Falhammar H and
Hedayati E: Lung carcinoids: A comprehensive review for clinicians.
Cancers (Basel). 15(5440)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hofland J, Herrera-Martinez AD, Zandee WT
and de Herder WW: Management of carcinoid syndrome: A systematic
review and meta-analysis. Endocr Relat Cancer. 26:R145–R156.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jacob N, Dasharathy SS, Bui V, Benhammou
JN, Grody WW, Singh RR and Pisegna JR: Generalized cytokine
increase in the setting of a multisystem clinical disorder and
carcinoid syndrome associated with a novel NLRP12 variant. Dig Dis
Sci. 64:2140–2146. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mota JM, Sousa LG and Riechelmann RP:
Complications from carcinoid syndrome: review of the current
evidence. Ecancermedicalscience. 10(662)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Caplin ME, Baudin E, Ferolla P, Filosso P,
Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, et
al: Pulmonary neuroendocrine (carcinoid) tumors: European
neuroendocrine tumor society expert consensus and recommendations
for best practice for typical and atypical pulmonary carcinoids.
Ann Oncol. 26:1604–1620. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Legare TB, Hamilton O, Dhannoon S and Ali
S: Non-islet cell tumor hypoglycemia: A rare cause of hypoglycemia
in pulmonary sarcomatoid cancer. Cureus. 9(e1972)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yamasaki H, Itawaki A, Morita M, Miyake H,
Yamamoto M, Sonoyama H, Tanaka S, Notsu M, Yamauchi M, Fujii Y, et
al: A case of insulin-like growth factor 2-producing
gastrointestinal stromal tumor with severe hypoglycemia. BMC Endocr
Disord. 20(60)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bodnar TW, Acevedo MJ and Pietropaolo M:
Management of non-islet-cell tumor hypoglycemia: A clinical review.
J Clin Endocrinol Metab. 99:713–722. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ata F, Choudry H, Khan AA, Anum Khamees I,
Al-Sadi A, Mohamed A, Malkawi L and Aljaloudi E: A systematic
review of literature on Insulin-like growth factor-2-mediated
hypoglycaemia in non-islet cell tumours. Endocrinol Diabetes Metab.
7(e00471)2024.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Nauck MA, Reinecke M, Perren A, Frystyk J,
Berishvili G, Zwimpfer C, Figge AM, Flyvbjerg A, Lankisch PG, Blum
WF, et al: Hypoglycemia due to paraneoplastic secretion of
insulin-like growth factor-I in a patient with metastasizing
large-cell carcinoma of the lung. J Clin Endocrinol Metab.
92:1600–1605. 2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gherbon A, Frandes M, Nicula M, Avram A
and Timar R: Igf-2 induced hypoglycemia associated with lung
sarcoma. Acta Endocrinol (Buchar). 18:232–237. 2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
McCall AL, Lieb DC, Gianchandani R,
MacMaster H, Maynard GA, Murad MH, Seaquist E, Wolfsdorf JI, Wright
RF and Wiercioch W: Management of individuals with diabetes at high
risk for hypoglycemia: An endocrine society clinical practice
guideline. J Clin Endocrinol Metab. 108:529–562. 2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wei LF, Weng XF, Huang XC, Peng YH, Guo HP
and Xu YW: IGFBP2 in cancer: Pathological role and clinical
significance (Review). Oncol Rep. 45:427–438. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Palani G, Stortz E and Moheet A: Clinical
presentation and diagnostic approach to hypoglycemia in adults
without diabetes mellitus. Endocr Pract. 29:286–294.
2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Isaacs D, Clements J, Turco N and Hartman
R: Glucagon: Its evolving role in the management of hypoglycemia.
Pharmacotherapy. 41:623–633. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Abell SK, Teng J, Dowling A, Hofman MS,
MacIsaac RJ and Sachithanandan N: Prolonged life-threatening
hypoglycaemia following dose escalation of octreotide LAR in a
patient with malignant polysecreting pancreatic neuroendocrine
tumour. Endocrinol Diabetes Metab Case Rep.
2015(140097)2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Iglesias P and Díez JJ: Management of
endocrine disease: A clinical update on tumor-induced hypoglycemia.
Eur J Endocrinol. 170:R147–R157. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
He D, Gong H, Pan J, Zhu F, Jiang X and Su
H: Recurrent Non-islet cell tumor hypoglycemia secondary to
hepatocellular carcinoma: Case report and literature review. Z
Gastroenterol. 62:752–758. 2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Karamanolis NN, Kounatidis D, Vallianou
NG, Alexandropoulos K, Kovlakidi E, Kaparou P, Karampela I,
Stratigou T and Dalamaga M: Paraneoplastic hypoglycemia: An
overview for optimal clinical guidance. Metabol Open.
23(100305)2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ghazi AA, Amirbaigloo A, Dezfooli AA,
Saadat N, Ghazi S, Pourafkari M, Tirgari F, Dhall D, Bannykh S,
Melmed S and Cooper O: Ectopic acromegaly due to growth hormone
releasing hormone. Endocrine. 43:293–302. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sohail S, Shafiq W, Sajjad K, Azmat U and
Naveed MA: Ectopic acromegaly secondary to bronchial tumour: A case
report of rare occurrence. J Cancer Allied Spec.
7(e397)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Katznelson L, Laws ER Jr, Melmed S,
Molitch ME, Murad MH, Utz A and Wass JA: Endocrine Society.
Acromegaly: An endocrine society clinical practice guideline. J
Clin Endocrinol Metab. 99:3933–3951. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Elenius H and Nieman LK: Recognition and
management of ectopic ACTH secreting tumors. J Endocr Soc.
9(bvae194)2025.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zendran I, Gut G, Kałużny M, Zawadzka K
and Bolanowski M: Acromegaly caused by ectopic growth hormone
releasing hormone secretion: A review. Front Endocrinol (Lausanne).
13(867965)2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Rosiek V, Kogut A and Kos-Kudła B:
Pro-gastrin-releasing peptide as a biomarker in lung neuroendocrine
neoplasm. Cancers (Basel). 15(3282)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Rossi RE, Elvevi A, Citterio D, Coppa J,
Invernizzi P, Mazzaferro V and Massironi S: Gastrinoma and
Zollinger Ellison syndrome: A roadmap for the management between
new and old therapies. World J Gastroenterol. 27:5890–5907.
2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Metz DC and Jensen RT: Zollinger-Ellison
syndrome. Yamada's Textbook of Gastroenterology, pp977-1003,
2022.
|
|
52
|
Cho MS and Kasi A: Zollinger-Ellison
syndrome. In: StatPearls. StatPearls Publishing, Treasure Island,
FL, 2025. https://www.ncbi.nlm.nih.gov/books/NBK537344/.
|
|
53
|
Scarpignato C, Gatta L, Zullo A and
Blandizzi C: SIF-AIGO-FIMMG Group; Italian Society of Pharmacology,
the Italian Association of Hospital Gastroenterologists, the
Italian Federation of General Practitioners. Effective and safe
proton pump inhibitor therapy in acid-related diseases-A position
paper addressing benefits and potential harms of acid suppression.
BMC Med. 14(179)2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Jin XF, Spampatti MP, Spitzweg C and
Auernhammer CJ: Supportive therapy in gastroenteropancreatic
neuroendocrine tumors: Often forgotten but important. Rev Endocr
Metab Disord. 19:145–158. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shao QQ, Zhao BB, Dong LB, Cao HT and Wang
WB: Surgical management of Zollinger-Ellison syndrome: Classical
considerations and current controversies. World J Gastroenterol.
25:4673–4681. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Verdugo MA, Soto RM, Salgado DL, Medrano
ME and León WA: Clinical and surgical management of
Zollinger-Ellison syndrome: A literature review. Int J Med Sci Clin
Res Stud. 2:1508–1511. 2022.
|
|
57
|
Guarnotta V, Martini C, Davì MV, Pizza G,
Colao A and Faggiano A: NIKE group. The Zollinger-Ellison syndrome:
Is there a role for somatostatin analogues in the treatment of the
gastrinoma? Endocrine. 60:15–27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ito T, Ramos-Alvarez I and Jensen RT:
Successful lifetime/long-term medical treatment of acid
hypersecretion in Zollinger-Ellison syndrome (ZES): Myth or fact?
Insights from an analysis of results of NIH long-term prospective
studies of ZES. Cancers (Basel). 15(1377)2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Metelski J, Metelska A, Sereda D, Nieścior
H and Szwed M: Zollinger-Ellison syndrome-review. J Educ Health
Sport. 12:523–532. 2022.
|
|
60
|
Yao JC, Fazio N, Singh S, Buzzoni R,
Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, et al:
Everolimus for the treatment of advanced, non-functional
neuroendocrine tumours of the lung or gastrointestinal tract
(RADIANT-4): A randomised, placebo-controlled, phase 3 study.
Lancet. 387:968–977. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Swerdloff RS and Ng JCM: Gynecomastia:
Etiology, diagnosis, and treatment. [Updated 2023 Jan 6]. In:
Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E,
de Herder WW, Dhatariya K, Dungan K, Hofland J et al (eds).
Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc,
2000.
|
|
62
|
Gowda H, Phatak SV, Manoj M and Ghanta P:
Paraneoplastic syndrome presenting with unilateral gynecomastia:
Ultrasonography, mammography, and strain elastography evaluation. J
Datta Meghe Inst Med Sci Univ. 17:421–423. 2022.
|
|
63
|
Cuhaci N, Polat SB, Evranos B, Ersoy R and
Cakir B: Gynecomastia: Clinical evaluation and management. Indian J
Endocrinol Metab. 18:150–158. 2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Peng J, Lv S, Liu L, Feng S and Xing N:
Lung neoplasm mimicking as ectopic pregnancy due to paraneoplastic
secretion of human chorionic gonadotropin: A case report and
literature review. Arch Gynecol Obstet. 303:607–614.
2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Matsukuma S, Obara K, Utsumi Y, Miyai K,
Takeo H, Oshika Y and Sensaki K: Focal positivity of
immunohistochemical markers for pulmonary squamous cell carcinoma
in primary pulmonary choriocarcinoma: A histopathological study.
Oncol Lett. 16:7256–7263. 2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Yang RH, Ting CH and Chu YK: Cannonball
lung metastases as a presenting feature of ectopic hCG expression.
J Oncol Sci. 2:58–62. 2016.
|
|
67
|
Sanjan G, Banerjee S, Dua R and Sharma P:
A lung cancer patient presenting with gynecomastia: An uncommon
paraneoplastic syndrome. Cureus. 16(e54758)2024.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Singh J, Swaminathan U, Sharada P, Alur
JB, Chowdhury P and Mrinal U: Estimation of expression of
beta-human chorionic gonadotropin levels through progression of
disease from normal to epithelial dysplasia to malignancy. J Oral
Maxillofac Pathol. 23:108–113. 2019.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lazopoulos A, Krimiotis D, Schizas NC,
Rallis T, Gogakos AS, Chatzinikolaou F, Tsiouda T, Zarogoulidis P,
Sarafis P, Kamparoudi P, et al: Galactorrhea, mastodynia and
gynecomastia as the first manifestation of lung adenocarcinoma. A
case report. Respir Med Case Rep. 26:146–149. 2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Yao H, Rui W, Zhang Y, Liu Y, Lin S, Tang
H, Zhao W and Wu Z: Prolactin-secreting lung adenocarcinoma
metastatic to the pituitary mimicking a prolactinoma: A case
report. Neurosurgery. 85:E773–E778. 2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Le Bescont A, Vitte AL, Debernardi A,
Curtet S, Buchou T, Vayr J, de Reyniès A, Ito A, Guardiola P,
Brambilla C, et al: Receptor-independent ectopic activity of
prolactin predicts aggressive lung tumors and indicates HDACi-based
therapeutic strategies. Antioxid Redox Signal. 23:1–14.
2015.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Legostaev VM, Ayrapetova TG, Kit OI,
Frantsiyants EM, Bandovkina VA, Babenkov OM, Chubaryan AV, Ezhova M
and Duritskiy MN: Ectopic prolactin production by lung cancer cells
as an indicator of aggressive nature of tumors. J Clin Oncol. 37
(15 Suppl)(e20021)2019.
|
|
73
|
Chen TY, Lee CH, Yang MY, Shen CC, Yang
YP, Chien Y, Huang YF, Lai CM and Cheng WY: Treatment of
hyperprolactinemia: A single-institute experience. J Chin Med
Assoc. 84:1019–1022. 2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Melmed S, Casanueva FF, Hoffman AR,
Kleinberg DL, Montori VM, Schlechte JA and Wass JA: Endocrine
Society. Diagnosis and treatment of hyperprolactinemia: An
endocrine society clinical practice guideline. J Clin Endocrinol
Metab. 96:273–288. 2011.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Barry L, Pather S, Gargya A and Marren A:
Prolactin-secreting leiomyoma causing hyperprolactinaemia
unresponsive to dopamine agonist therapy and resolution following
myomectomy. Case Rep Endocrinol. 2021(5553187)2021.PubMed/NCBI View Article : Google Scholar
|
